A61K 31/37
Coumarins
Official title: Coumarins, e.g. psoralen
A61K31/37 (Coumarins) appears on 562 US grants and 843 published applications in this corpus.
Search patents in A61K- Granted patents
- 562
- Published applications
- 843
- Assignees
- 473
- Inventors
- 1,756
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 1 | 0 |
| 1994 | 4 | 0 |
| 1995 | 8 | 0 |
| 1996 | 14 | 0 |
| 1997 | 17 | 0 |
| 1998 | 14 | 0 |
| 1999 | 17 | 0 |
| 2000 | 18 | 0 |
| 2001 | 23 | 12 |
| 2002 | 16 | 19 |
| 2003 | 15 | 19 |
| 2004 | 11 | 22 |
| 2005 | 10 | 23 |
| 2006 | 10 | 22 |
| 2007 | 6 | 30 |
| 2008 | 5 | 42 |
| 2009 | 11 | 14 |
| 2010 | 11 | 21 |
| 2011 | 15 | 30 |
| 2012 | 14 | 30 |
| 2013 | 20 | 27 |
| 2014 | 25 | 30 |
| 2015 | 16 | 34 |
| 2016 | 24 | 34 |
| 2017 | 23 | 30 |
| 2018 | 16 | 29 |
| 2019 | 25 | 44 |
| 2020 | 32 | 40 |
| 2021 | 28 | 54 |
| 2022 | 19 | 39 |
| 2023 | 18 | 55 |
| 2024 | 25 | 51 |
| 2025 | 19 | 56 |
| 2026 | 18 | 36 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for increasing T cell function15 Sep 2026US 12,734,150 B2Ludwig Institute for Cancer Research
- Composition for inhibiting Parkinson's disease and method of manufacturing the same1 Sep 2026US 12,721,824 B2Forte Capital Ltd.
- Biomarkers for the diagnosis of atrial fibrillation cause of stroke25 Aug 2026US 12,716,097 B2Ischemia Care LLC
- Sulfated C19 steroid hormones to treat and/or prevent proteotoxicity in protein-aggregation diseases11 Aug 2026US 12,702,673 B2Universidad Pablo De Olavide
- Compositions and methods for treating granulomatosis with polyangiitis11 Aug 2026US 12,702,701 B2Canem Holdings, LLC
- Lipolytic and antiadipogenic coumarin derivatives8 Oct 2026US 2026/0306446 A1Karl-Franzens-Universität Graz
- Compositions and methods using thymol and/or carvacrol for induction of autophagy1 Oct 2026US 2026/0294840 A1Societe des Produits Nestle S. A.
- Multi Ingredient Natural Products Composition And Method Of Use1 Oct 2026US 2026/0294866 A1Visionary Ventures LLC
- Inhibiting mitogen-activated protein (map)/erk kinase (mek)1 and mek2 and related methods of treatment24 Sep 2026US 2026/0284005 A1Immuneering Corporation
- Combination therapies for homologous recombination deficient cancers24 Sep 2026US 2026/0284045 A1
Most cited
By later US patents
- Spine distraction implant and method1,139US 5,836,948 ASaint Francis Medical Technologies, LLC · 1998
- Spine distraction implant and method928US 5,860,977 ASaint Francis Medical Technologies, LLC · 1999
- Spine distraction implant847US 6,048,342 ASt. Francis Medical Technologies, Inc. · 2000
- Spine distraction implant736US 6,068,630 ASt. Francis Medical Technologies, Inc. · 2000
- Supplemental spine fixation device and method697US 6,451,019 B1St. Francis Medical Technologies, Inc. · 2002